BCPC Insider Trading

Insider Ownership Percentage: 1.25%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,395,387.50

Balchem Insider Trading History Chart

This chart shows the insider buying and selling history at Balchem by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Balchem Share Price & Price History

Current Price: $166.13
Price Change: Price Decrease of -2.89 (-1.71%)
As of 05/28/2025 05:00 PM ET

This chart shows the closing price history over time for BCPC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JulAugSepOctNovDecJanFebMarAprMay$166.13Closing price on 05/28/25:

SEC Filings (Institutional Ownership Changes) for Balchem (NASDAQ:BCPC)

87.91% of Balchem stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCPC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$202Mbought$208MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M$0$200MTotal InflowsTotal Outflows
Balchem logo
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Read More on Balchem

Today's Range

Now: $166.13
Low: $166.00
High: $169.16

50 Day Range

MA: $162.03
Low: $150.50
High: $170.45

52 Week Range

Now: $166.13
Low: $145.70
High: $186.03

Volume

107,620 shs

Average Volume

138,017 shs

Market Capitalization

$5.42 billion

P/E Ratio

42.27

Dividend Yield

0.52%

Beta

0.93

Who are the company insiders with the largest holdings of Balchem?

Balchem's top insider investors include:
  1. Theodore L Harris (CEO)
  2. David B Fischer (Director)
  3. William A Backus (CAO)
  4. Gunsteren Job Leonard Van (SVP)
  5. Michael Robert Sestrick (SVP)
Learn More about top insider investors at Balchem.

Who are the major institutional investors of Balchem?

Balchem's top institutional investors include:
  1. Vanguard Group Inc. — 11.80%
  2. Conestoga Capital Advisors LLC — 3.59%
  3. APG Asset Management N.V. — 3.54%
  4. Geneva Capital Management LLC — 2.55%
  5. Northern Trust Corp — 1.22%
  6. Charles Schwab Investment Management Inc. — 1.13%
Learn More about top institutional investors of Balchem stock.

Which major investors are selling Balchem stock?

During the last quarter, BCPC stock was sold by these institutional investors:
  1. APG Asset Management N.V.
  2. Vanguard Group Inc.
  3. Invesco Ltd.
  4. Montanaro Asset Management Ltd
  5. New Age Alpha Advisors LLC
  6. Envestnet Asset Management Inc.
  7. Raymond James Financial Inc.
  8. Royal Bank of Canada

Which major investors are buying Balchem stock?

Within the previous quarter, BCPC stock was bought by institutional investors including:
  1. Nuveen LLC
  2. GAMMA Investing LLC
  3. Millennium Management LLC
  4. Goldman Sachs Group Inc.
  5. Jacobs Levy Equity Management Inc.
  6. Assenagon Asset Management S.A.
  7. Congress Asset Management Co.
  8. Strs Ohio